None listed
Conditions
Interventions
Procedure/Surgery : A person who voluntarily signs a clinical research agreement and satisfies the selection criteria is enrolled in this clinical study.
Subjects were randomly assigned to the experi
Sponsors
Zurich University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. = 18 years of age 2. In need of at least two or more unilateral implants at the posterior region either in the maxilla or the mandible (excl. third molars) (single crowns only) 3. Primary implant stability with insertion torque > 30N 4. Presence of two adjacent teeth at the implant site 5. Adequate oral hygiene (Bleeding on probing <20%; Plaque index <20%); 6. Capability to comply with the study procedures 7. Signed Informed Consent Form
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women 2. Systemic or local conditions presenting a contraindication to implant treatment 3. Known or suspected non-compliance, drug or alcohol abuse 4. Smokers (>10 cigarettes/day) 5. Currently taking drugs that influence bone metabolism 6. Use of bisphosphonates in the last 4 years 7. History of malignancy, radiotherapy or chemotherapy for malignancy in the past 5 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients’ satisfaction using Patient Reported Outcome Measures (PROMs) (VAS), after 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Profilometric changes of the buccal soft tissues via superimposing the digital impressions;Accuracy of implant position by means of cone-beam CT;Fit of final reconstruction measured by the need for adjustment either by the dentist or the dental technician;Technical outcomes (efficacy/USPHS) after insertion of the final reconstruction, and at 1-year follow-up;Patient’s reported outcome measures;Perceived difficulty/ease of use rated by dentists at implant placement and at the visit for Final Prosthesis (BL1 and BL2);Efficiency (time) assessed at implant placement and at visit of Final Prosthesis (BL1 and BL2);Marginal bone level (implant shoulder to first bone-to-implant-contact) after final reconstruction (at visits for Evaluation of Final Prosthesis), 6 months and 1-year follow-up;Implant survival at 6 months and 1-year follow-up;Schedule of visits and additional visits (efficiency);Treatment cost;Peri-implant clinical parameters (PD, REC and KER, PI, BOP) at the implant sites and adjacent teeth | — |
Countries
Korea, Republic of
Contacts
Public ContactDaMi Kim
Yonsei University Health System, Dental Hospital
Outcome results
None listed